Product Code: PM4144
The global HERG screening market size is expected to reach USD 6.10 million by 2032, according to a new study by Polaris Market Research. The report "HERG Screening Market Share, Size, Trends, Industry Analysis Report, By Product Type (Gene KCNH2, Mutant KCNH2, Others); By Ion Channel; By Application; By Region; Segment Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Market is being driven by the increasing number of innovative medication approvals and the rising prevalence of cardiac disorders. In 2019, 9.6 Mn men & 8.9 Mn women died from the cardiovascular diseases across the globe, with further than 6 Mn of them aged 30-70. Such deaths were majorly from India, Russia, China, United States, & Indonesia. Nonetheless, unexplored markets are anticipated to create a lucrative potential for this market's growth soon.
Rise in the incidence of heart illnesses and the number of people suffering from heart ailments are likely to drive market growth. Furthermore, a rise in the approvals of novel drug entities along with in silico techniques is projected to contribute in market expansion. For instance, machine learning based algorithmic models have been developed to screen the DrugBank database for the potential hERG blockers. To create cutting-edge machine learning models, were combined with gradient boosting tree & deep-rooted neural algorithms.
In recent years, researchers have concentrated on avoiding the hyper-activity of the hERG K+ channel while at the same time testing novel drugs for the pro-arrhythmic potential, as hERG block is a common characteristic of the many pro-arrhythmic substances linked with the "Torsades de Pointes" in people.
The rising prevalence of cardiac disease and medicine development to treat it may enhance the use of HERG screening tools. Furthermore, the drop in price to more reasonable levels may assist to increase the use of HERG screening kits.
There were no precise diagnostic tests available to detect COVID-19 in patients during the early stages of the epidemic. Because COVID-19 diagnostic tests were unavailable, diagnostic manufacturers saw profitable chances to create COVID-19 diagnostic kits. These firms gained an advantage over other diagnostics players by leveraging on demand for COVID-19 diagnostic tests, which enables them sustain revenues in such a situation. Fast C-type inactivation provides specific functional features to the hERG potassium channel, and its relationship with inherited and acquired cardiac arrhythmias makes atomic-level hERG inactivation mechanism research critical.
HERG Screening market Report Highlights
The KCNH2 gene is part of a wide family of genes that code for potassium channel instructions and a KCNH2 mutation causes cardiac arrhythmia, hence share a significant hold in the market share.
Voltage gated ion channels dominated the worldwide market, along with the fastest-growing sector which is ion gated channels.
The antiarrhythmic medication application sector is expected to account for a sizable market share as it modifies the functional activity of the ion channel.
North America accounted for the largest revenue share primarily due presence of key companies & awareness among individuals
The global players include: Abcam PLC, PerkinElmer Company, ABR-Affinity Bioreagents, AstraZeneca, Aureus Sciences, Aurora Sciences, AVIVA Biosciences, B'SyS GmbH, Caliper, Fujifilm Cellular Dynamics, Cambridge Biosciences, ChanTest Corporation, Charles River Laboratories, ChemAxon, Eurofins-Cerep, and Molecular Devices.
Polaris Market Research has segmented the HERG screening market report based on product type, ion channel, application, and region:
HERG Screening, Product Type Outlook (Revenue - USD Million, 2019 - 2032)
- Gene KCNH2
- Mutant KCNH2
- Others
HERG Screening, Ion Channel Outlook (Revenue - USD Million, 2019 - 2032)
- Voltage Gated
- Ligand Gated
- Others
HERG Screening, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Antiarrhythmic
- Antipsychotic
- Antibiotic
- Others
HERG Screening, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global HERG Screening Market Insights
- 4.1. HERG Screening Market - Application Snapshot
- 4.2. HERG Screening Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Drug Discovery and Development
- 4.2.1.2. Rising Incidence of Cardiovascular Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Screening Assays
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. HERG Screening Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global HERG Screening Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 5.3. Gene KCNH2
- 5.3.1. Global HERG Screening Market, by Gene KCNH2, by Region, 2019-2032 (USD Million)
- 5.4. Mutant KCNH2
- 5.4.1. Global HERG Screening Market, by Mutant KCNH2, by Region, 2019-2032 (USD Million)
- 5.5 Others
- 5.5.1. Global HERG Screening Market, by Others, by Region, 2019-2032 (USD Million)
6. Global HERG Screening Market, by Ion Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 6.3. Voltage Gated
- 6.3.1. Global HERG Screening Market, by Voltage Gated, by Region, 2019-2032 (USD Million)
- 6.4. Ligand Gated
- 6.4.1. Global HERG Screening Market, by Ligand Gated, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global HERG Screening Market, by Others, by Region, 2019-2032 (USD Million)
7. Global HERG Screening Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global HERG Screening Market, by Application, 2019-2032 (USD Million)
- 7.3. Antiarrhythmic
- 7.3.1. Global HERG Screening Market, by Antiarrhythmic, By Region, 2019-2032 (USD Million)
- 7.4. Antipsychotic
- 7.4.1. Global HERG Screening Market, by Antipsychotic, By Region, 2019-2032 (USD Million)
- 7.5. Antibiotic
- 7.5.1. Global HERG Screening Market, by Antibiotic, By Region, 2019-2032 (USD Million)
- 7.6. Others
- 7.6.1. Global HERG Screening Market, by Others, By Region, 2019-2032 (USD Million)
8. Global HERG Screening Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. HERG Screening Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. HERG Screening Market - North America
- 8.3.1. North America: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.3.2. North America: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.3.3. North America: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.3.4. HERG Screening Market - U.S.
- 8.3.4.1. U.S.: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.3.5. HERG Screening Market - Canada
- 8.3.5.1. Canada: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.3.5.3. Canada: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4. HERG Screening Market - Europe
- 8.4.1. Europe: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.3. Europe: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.4. HERG Screening Market - UK
- 8.4.4.1. UK: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.4.3. UK: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.5. HERG Screening Market - France
- 8.4.5.1. France: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.5.3. France: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.6. HERG Screening Market - Germany
- 8.4.6.1. Germany: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.6.3. Germany: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.7. HERG Screening Market - Italy
- 8.4.7.1. Italy: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.7.3. Italy: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.8. HERG Screening Market - Spain
- 8.4.8.1. Spain: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.8.3. Spain: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.9. HERG Screening Market - Netherlands
- 8.4.9.1. Netherlands: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.10. HERG Screening Market - Russia
- 8.4.10.1. Russia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.10.3. Russia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5. HERG Screening Market - Asia Pacific
- 8.5.1. Asia Pacific: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.4. HERG Screening Market - China
- 8.5.4.1. China: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.4.3. China: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.5. HERG Screening Market - India
- 8.5.5.1. India: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.5.3. India: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.6. HERG Screening Market - Malaysia
- 8.5.6.1. Malaysia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.7. HERG Screening Market - Japan
- 8.5.7.1. Japan: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.7.3. Japan: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.8. HERG Screening Market - Indonesia
- 8.5.8.1. Indonesia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.9. HERG Screening Market - South Korea
- 8.5.9.1. South Korea: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6. HERG Screening Market - Middle East & Africa
- 8.6.1. Middle East & Africa: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.4. HERG Screening Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.5. HERG Screening Market - UAE
- 8.6.5.1. UAE: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.5.3. UAE: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.6. HERG Screening Market - Israel
- 8.6.6.1. Israel: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.6.3. Israel: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.7. HERG Screening Market - South Africa
- 8.6.7.1. South Africa: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7. HERG Screening Market - Latin America
- 8.7.1. Latin America: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.3. Latin America: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7.4. HERG Screening Market - Mexico
- 8.7.4.1. Mexico: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7.5. HERG Screening Market - Brazil
- 8.7.5.1. Brazil: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7.6. HERG Screening Market - Argentina
- 8.7.6.1. Argentina: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abcam PLC
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. ABR-Affinity Bioreagents
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. AstraZeneca
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Aureus Sciences
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Aurora Sciences
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. AVIVA Biosciences
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. B'SyS GmbH
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Caliper
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Cambridge Biosciences
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Cellular Dynamics
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. ChanTest Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Charles River Laboratories
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. ChemAxon
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Eurofins-Cerep SA
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Molecular Devices
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. PerkinElmer Company
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development